🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06394908
Enrolling by invitation Observational

Registry of MIUS for Urolithiasis (ReMIUS-U)

NCT06394908 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2023-05-10
Last updated
2025-08-20

Condition(s) studied

UrolithiasisStone, KidneyStone UreterComplication of Surgical Procedure

Study summary

The purpose of this registry is to collect data on patients who have undergone minimally invasive treatments for urinary system stone disease, including percutaneous nephrolithotomy (PCNL), shock wave lithotripsy (SWL), semi-rigid ureterorenoscopy (URS), and flexible ureterorenoscopy (F-URS).

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * To have a medical indication for urolithiasis * Complete data of treatment and follow-up course * Patients with consent * Patients \> 18 years-old * Patients \< 18 years-old Exclusion Criteria: * Missing data * Patients without consent * Not to have a medical indication for urolithiasis treatment * To have a contraindication for urolithiasis treatment

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Marmara University Hospital Istanbul Turkey (Türkiye)

More Marmara University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06394908 on ClinicalTrials.gov ↗ ← All trials in Turkey